Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Tumor Protein, Translationally-Controlled 1 MeSH Descriptor Data 2026
A highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival. Also, Tpt1 identified as a direct target gene of P53 tumor suppression.
Entry Term(s)
Histamine Releasing Factor
Histamine Releasing Factor, Lymphocyte-Dependent
Histamine-Releasing Factor (IgE-Dependent)
Protein P23, Ehrlich Ascites Tumor
TPT1 Protein
Translationally-Controlled Tumor Protein
Registry Numbers
0
Public MeSH Note
2022; TUMOR PROTEIN, TRANSLATIONALLY-CONTROLLED 1 was indexed under BIOMARKERS, TUMOR 1987-2021; under CALCIUM-BINDING PROTEINS 1997-2002; under GROWTH SUBSTANCES 1995-2002; under LYMPHOKINES 1985-2002; and under NEOPLASM PROTEINS 1994-2002
A highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival. Also, Tpt1 identified as a direct target gene of P53 tumor suppression.